RxDoctor Payments Data

Kevin Giacontiere, PA

Surgical · Austin, TXNPI 1942205430

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.3% of the total across 309 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Among surgical clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,080in general payments, 2019–2025

Across 309 payments — averaging $16.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Incyte Corporation$686
  • Galderma Laboratories, L.p.$671
  • Johnson & Johnson$449
  • Lilly USA, LLC$343
  • Amgen$256
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$4,69092%
  • Education$3908%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,080 in reported general payments places this provider in the 90th percentile of 804 surgical providers in Texas.

See all surgical providers in Texas

Medicare billing

Part B allowed, 2024
$419,981
Medicare patients
1,017
Services billed
6,904

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab13$46,871
Clobetasol Propionate154$6,130
Doxycycline Hyclate149$5,549
Triamcinolone Acetonide189$2,789
Fluorouracil29$1,934
Ketoconazole46$1,211
Metronidazole27$1,109
Minoxidil57$971
Mupirocin95$764
Clindamycin Phosphate15$760
ValacyclovirValacyclovir Hcl18$543
Desonide17$480
Imiquimod12$403
Cephalexin25$308
Hydroxyzine Hcl38$292

Paid to pharmacies, not to this prescriber.

Other surgical in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →